The transcriptional regulator BCL6 participates in the secondary gene regulatory response to vitamin D

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 3, 2015, Pages 300-308

  Nurminen, Veijo ^a   Neme, Antonio ^a   Ryynänen, Jussi ^a   Heikkinen, Sami ^a   Seuter, Sabine ^a   Carlberg, Carsten ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

BCL6; ChIP seq; FAIRE seq; Secondary transcriptional response; VDR; Vitamin D

Indexed keywords

CALCITRIOL; MESSENGER RNA; PROTEIN BCL 6; VITAMIN D RECEPTOR; BCL6 PROTEIN, HUMAN; CCCTC-BINDING FACTOR; DIHYDROXY-VITAMIN D3; DNA-BINDING PROTEINS; ELF4 PROTEIN, HUMAN; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; NFE2 PROTEIN, HUMAN; POU4F2 PROTEIN, HUMAN; PROTEIN BINDING; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTOR BRN-3B; TRANSCRIPTION FACTORS; VDR PROTEIN, HUMAN; VITAMIN D;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; MONOCYTE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION; ANALOGS AND DERIVATIVES; BINDING SITES; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMANS; METABOLISM; TRANSCRIPTIONAL ACTIVATION;

BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; PROTEIN BINDING; RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTOR BRN-3B; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VITAMIN D;

EID: 84921460260     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.12.001     Document Type: Article

References (41)

1. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689S-1696S.
2. Bouillon R., Carmeliet G., Lieben L., Watanabe M., Perino A., Auwerx J., Schoonjans K., Verstuyf A. Vitamin D and energy homeostasis-of mice and men. Nat. Rev. Endocrinol. 2014, 10:79-87.
3. Feldman D., Krishnan A.V., Swami S., Giovannucci E., Feldman B.J. The role of vitamin D in reducing cancer risk and progression. Nat. Rev. Cancer 2014, 14:342-357.
4. Hewison M. An update on vitamin D and human immunity. Clin. Endocrinol. (Oxf.) 2012, 76:315-325.
5. Holick M.F. Vitamin D deficiency in 2010: health benefits of vitamin D and sunlight: a D-bate. Nat. Rev. Endocrinol. 2011, 7:73-75.
6. Levis S., Gomez A., Jimenez C., Veras L., Ma F., Lai S., Hollis B., Roos B.A. Vitamin D deficiency and seasonal variation in an adult South Florida population. J. Clin. Endocrinol. Metab. 2005, 90:1557-1562.
7. Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 2014, 5:167.
8. Carlberg C., Molnár F. Current status of vitamin D signaling and its therapeutic applications. Curr. Top. Med. Chem. 2012, 12:528-547.
9. Carlberg C., Campbell M.J. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013, 78:127-136.
10. Phillips J.E., Corces V.G. CTCF: master weaver of the genome. Cell 2009, 137:1194-1211.
11. Schmidt D., Schwalie P.C., Wilson M.D., Ballester B., Gonçalves A., Kutter C., Brown G.D., Marshall A., Flicek P., Odom D.T. Waves of retrotransposon expansion remodel genome organization and CTCF binding in multiple mammalian lineages. Cell 2012, 148:335-348.
12. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G., Huang P.Y., Welboren W.J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.K., Liu E.T., Wei C., Cheung E., Ruan Y. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
13. ENCODE-Project-Consortium, Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
14. Seuter S., Neme A., Carlberg C. Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening. PLoS ONE 2014, 9:e96184.
15. Park P.J. ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 2009, 10:669-680.
16. 3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011, 39:9181-9193.
17. Tuoresmäki P., Väisänen S., Neme A., Heikkinen S., Carlberg C. Patterns of genome-wide VDR locations. PLoS ONE 2014, 9:e96105.
18. Giresi P.G., Kim J., McDaniell R.M., Iyer V.R., Lieb J.D. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res. 2007, 17:877-885.
19. Seuter S., Pehkonen P., Heikkinen S., Carlberg C. Dynamics of 1α,25-dihydroxyvitamin D-dependent chromatin accessibility of early vitamin D receptor target genes. Biochim. Biophys. Acta 2013, 1829:1266-1275.
20. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 1980, 26:171-176.
21. Seuter S., Ryynänen J., Carlberg C. The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D in human monocytes and macrophages. J. Steroid Biochem. Mol. Biol. 2014, 144:12-18.
22. 3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Res. 2013, 41:110-124.
23. Thorvaldsdottir H., Robinson J.T., Mesirov J.P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 2013, 14:178-192.
24. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
25. 3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells. PLoS One 2013, 8:e78170.
26. Zella L.A., Meyer M.B., Nerenz R.D., Lee S.M., Martowicz M.L., Pike J.W. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 2010, 24:128-147.
27. Hurtz C., Hatzi K., Cerchietti L., Braig M., Park E., Kim Y.M., Herzog S., Ramezani-Rad P., Jumaa H., Muller M.C., Hofmann W.K., Hochhaus A., Ye B.H., Agarwal A., Druker B.J., Shah N.P., Melnick A.M., Muschen M. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J. Exp. Med. 2011, 208:2163-2174.
28. Di Noto R., Luciano L., Lo Pardo C., Ferrara F., Frigeri F., Mercuro O., Lombardi M.L., Pane F., Vacca C., Manzo C., Salvatore F., Rotoli B., Del Vecchio L. JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis. Leukemia 1997, 11:1554-1564.
29. Klein E., Ben-Bassat H., Neumann H., Ralph P., Zeuthen J., Polliack A., Vánky F. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int. J. Cancer 1976, 18:421-431.
30. Vaquerizas J.M., Kummerfeld S.K., Teichmann S.A., Luscombe N.M. A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 2009, 10:252-263.
31. Stogios P.J., Downs G.S., Jauhal J.J., Nandra S.K., Prive G.G. Sequence and structural analysis of BTB domain proteins. Genome Biol. 2005, 6:R82.
32. Basso K., Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv. Immunol. 2010, 105:193-210.
33. Ci W., Polo J.M., Melnick A. B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr. Opin. Hematol. 2008, 15:381-390.
34. Ghetu A.F., Corcoran C.M., Cerchietti L., Bardwell V.J., Melnick A., Prive G.G. Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer. Mol. Cell 2008, 29:384-391.
35. Hatzi K., Jiang Y., Huang C., Garrett-Bakelman F., Gearhart M.D., Giannopoulou E.G., Zumbo P., Kirouac K., Bhaskara S., Polo J.M., Kormaksson M., MacKerell A.D., Xue F., Mason C.E., Hiebert S.W., Prive G.G., Cerchietti L., Bardwell V.J., Elemento O., Melnick A. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. Cell. Reprogram. 2013, 4:578-588.
36. Kurata M., Maesako Y., Ueda C., Nishikori M., Akasaka T., Uchiyama T., Ohno H. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6. Cancer Res. 2002, 62:6224-6230.
37. (waf1/cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res. 2011, 39:2045-2056.
38. 3 target genes in a human myeloid leukemia cell line. Cancers 2013, 5:1221-1241.
39. 3 status in the hematopoietic system. J. Nutr. Biochem. 2014, 25:875-884.
40. Handoko L., Xu H., Li G., Ngan C.Y., Chew E., Schnapp M., Lee C.W., Ye C., Ping J.L., Mulawadi F., Wong E., Sheng J., Zhang Y., Poh T., Chan C.S., Kunarso G., Shahab A., Bourque G., Cacheux-Rataboul V., Sung W.K., Ruan Y., Wei C.L. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 2011, 43:630-638.
41. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:R34.